Synovial Sarcoma - Online Support Group

Halaven (Eribulin, E7389)


The name of this drug was mentioned yesterday at the SFA Educational Conference because large trials (likely phase III) are scheduled to start sometimes soon. I had never heard of this name so I did my little search and found the results from the European phase II study :


The response rate for synovial sarcoma is not very impressive unfortunately...


Phase III trial of eribulin in soft tissue sarcoma shows overall survival benefit in primary endpoint:


It's not clear whether there was any patient with synovial sarcoma in this study. We'll have to wait for the data.

Results of the phase 2 trial are here: